UGP2 Antibodies

Santa Cruz Biotechnology provides a broad selection of UGP2 monoclonal antibodies for research focused on understanding UGP2's role in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UGP2, or UDP-glucose pyrophosphorylase 2, plays a crucial role in carbohydrate metabolism by catalyzing the conversion of glucose-1-phosphate and UTP to UDP-glucose and pyrophosphate. UDP-glucose pyrophosphorylase 2 is essential for glycogen synthesis and the biosynthesis of glycosylated molecules, making it vital for energy storage and cellular signaling. Research involving UGP2 has revealed its significance in metabolic pathways and potential implications in various disorders. Scientists studying UGP2 continue to uncover new insights about its regulatory mechanisms and physiological importance. Investigating UDP-glucose pyrophosphorylase 2 can lead to breakthroughs in understanding metabolic disorders and identifying therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of UGP2's role in human health and disease.